Search By Initial

Name Index G

• GSK-1070916 (Catalog# : 111011, Cas# : 942918-07-2)GSK1070916 is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3
• GSK269962A (Catalog# : 102206, Cas# : 850664-21-0)GSK269962A(CAS 850664-21-0) is a potent ROCK inhibitor (IC50 values are 1.6 and 4 nM
• Gandotinib(LY2784544) (Catalog# : 91415, Cas# : 1229236-86-5)Gandotinib is an orally bioavailable imidazopyridazine and inhibitor of Janus kinase
• GW 627368 (Catalog# : 91003, Cas# : 439288-66-1)GW 627368X is a potent and selective competitive antagonist of the EP4 receptor with
• GDC-0810 ( Brilanestrant , ARN-810 ) (Catalog# : 90731, Cas# : 1365888-06-7)GDC-0810 (Brilanestrant, ARN-810, RG6046) is a selective estrogen receptor degrader (
• G007-LK (Catalog# : 62908, Cas# : 1380672-07-0)G007-LK is specific tankyrase 1/2 inhibitor.G007-LK (66) displayed high selectivity t
• GDC-0349 (Catalog# : 62702, Cas# : 1207360-89-1)GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR.
• Galeterone (Catalog# : 62003, Cas# : 851983-85-2)Galeterone(VN/124-1,TOK001) is a highly selective, multi-targeted, oral small molecul
• Gimeracil (Catalog# : 52804, Cas# : 103766-25-2)Gimeracil(Gimestat) is an inhibitor of dihydropyrimidine dehydrogenase (DPYD), which
• GSK 525762A (Catalog# : 52745, Cas# : 1260907-17-2)GSK 525762A (I-BET 762) is an inhibitor for BET proteins with IC50 of ~35 nM.
• GSK429286A (Catalog# : 52629, Cas# : 864082-47-3)GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM,
• GSK1059615 (Catalog# : 52628, Cas# : 958852-01-2)GSK1059615 is a dual inhibitor of PI3K/// (reversible) and mTOR with IC50 of 0.4 nM/0
• GKT137831 (Catalog# : 52627, Cas# : 1218942-37-0)GKT137831 is a novel and specific dual Nox1/Nox4 inhibitor with Ki of 14040 nM and 11
• GSK2636771 (Catalog# : 52618, Cas# : 1372540-25-4)GSK2636771 is a potent, orally bioavailable and selective inhibitor of PI3K (0.89 nM)
• GS-7340 (Catalog# : 52611, Cas# : 379270-37-8)GS-7340(Tenofovir alafenamide) is a prodrug of tenofovir (TFV) that more efficiently
• GSK2110183 (Catalog# : 52584, Cas# : 1047634-63-8)GSK2110183 is an orally bioavailable, selective, ATP-competitive and potent pan-Akt i
• GW788388 (Catalog# : 52305, Cas# : 452342-67-5)GW788388 is a potent and selective inhibitor of ALK5 with IC50 of 18 nM, also inhibit
• GNF-5 (Catalog# : 52216, Cas# : 778277-15-9)GNF-5, an analogue of GNF-2 with improved pharmacokinetic properties, is a selective
• GNF-2 (Catalog# : 52301, Cas# : 778270-11-4)GNF-2 is a highly selective non-ATP competitive inhibitor of oncogenic Bcr-Abl activi
• GS967 (Catalog# : 52216, Cas# : 1262618-39-2)GS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late
• GBR 12935 dihydrochloride (Catalog# : 52404, Cas# : 67469-81-2)GBR 12935 2Hcl is a potent, and selective dopamine reuptake inhibitor.
• GSK126 (Catalog# : 52208, Cas# : 1346574-57-9)GSK126 is a potent, highly selectiveEZH2 methyltransferaseinhibitor withIC50of 9.9 nM
• GSK503 (Catalog# : 51805, Cas# : 1346572-63-1)GSK-503 is a potent EZH2 inhibitor with potential anticancer activity. Reference: 1.
• GW9662 (Catalog# : 52304, Cas# : 22978-25-2)GW9662 is a selective PPAR antagonist forPPARwithIC50of 3.3 nM, with at least 100 to
• GNE-317 (Catalog# : 52215, Cas# : 1394076-92-6)GNE-317 is a potent, brain-penetrantPI3Kinhibitor
• Genz-123346 (Catalog# : S1419, Cas# : 491833-30-8)Genz-123346 free base is an inhibitor of GL1 synthase that blocks the conversion of c
• Galunisertib(LY2157299) (Catalog# : 52017, Cas# : 700874-72-2)Galunisertib (LY2157299)isselective TGF- receptor kinase inhibitor. Galunisertib was
• GSK3787 (Catalog# : 52018, Cas# : 188591-46-0)GSK3787 is as a selective and irreversible antagonist ofPPARwithpIC50of 6.6, with no
• GSK 2656157 (Catalog# : 52019, Cas# : 1337532-29-2)GSK2656157 is an ATP-competitive and highly selective inhibitor ofPERKwithIC50of 0.9
• Golvatinib (E7050) (Catalog# : 52020, Cas# : 928037-13-2)Golvatinib (E7050) is a dualc-MetandVEGFR-2inhibitor with IC50 of 14 nM and 16 nM, do